Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Type of study
Language
Document Type
Year range
1.
Int J Mol Sci ; 22(18)2021 Sep 10.
Article in English | MEDLINE | ID: covidwho-1409705

ABSTRACT

The inhibition mechanism of the main protease (Mpro) of SARS-CoV-2 by ebselen (EBS) and its analog with a hydroxyl group at position 2 of the benzisoselenazol-3(2H)-one ring (EBS-OH) was studied by using a density functional level of theory. Preliminary molecular dynamics simulations on the apo form of Mpro were performed taking into account both the hydrogen donor and acceptor natures of the Nδ and Nε of His41, a member of the catalytic dyad. The potential energy surfaces for the formation of the Se-S covalent bond mediated by EBS and EBS-OH on Mpro are discussed in detail. The EBS-OH shows a distinctive behavior with respect to EBS in the formation of the noncovalent complex. Due to the presence of canonical H-bonds and noncanonical ones involving less electronegative atoms, such as sulfur and selenium, the influence on the energy barriers and reaction energy of the Minnesota hybrid meta-GGA functionals M06, M06-2X and M08HX, and the more recent range-separated hybrid functional wB97X were also considered. The knowledge of the inhibition mechanism of Mpro by the small protease inhibitors EBS or EBS-OH can enlarge the possibilities for designing more potent and selective inhibitor-based drugs to be used in combination with other antiviral therapies.


Subject(s)
Antiviral Agents/pharmacology , COVID-19 Drug Treatment , Coronavirus 3C Proteases/antagonists & inhibitors , Isoindoles/pharmacology , Organoselenium Compounds/pharmacology , Protease Inhibitors/pharmacology , Antiviral Agents/therapeutic use , Binding Sites/drug effects , COVID-19/virology , Catalytic Domain/drug effects , Coronavirus 3C Proteases/metabolism , Drug Design , Humans , Isoindoles/chemistry , Isoindoles/therapeutic use , Molecular Docking Simulation , Molecular Dynamics Simulation , Organoselenium Compounds/chemistry , Organoselenium Compounds/therapeutic use , Protease Inhibitors/chemistry , Protease Inhibitors/therapeutic use , SARS-CoV-2/drug effects , SARS-CoV-2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL